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Acute postoperative pain remains one of the major
challenges of pain medicine. Although various meth-
ods and drugs have been proposed to manage periopera-
tive pain, oral and intravenous opioid analgesics are still
among the most common medications. However, their
potential short- and long-term adverse effects can limit
their application (1). Also, an increase in the dose of opi-
oids during surgery may not always result in better post-
operative pain management, and there are concerns about
the faster onset and higher severity of acute postoperative
pain, known as opioid-induced hyperalgesia (2).
To reduce the consumption of perioperative opioids,
various drugs and methods have been studied to date,
including non-opioids, adjuvants, and regional, periph-
eral, and neuraxial blocks. Nevertheless, the application of
each of these methods and drugs requires specific knowl-
edge, experience, equipment, arrangements, and care (3-
7). Many clinical studies have been published on the ap-
plication of multimodal analgesia in a variety of surgeries.
In these studies, the addition of adjuvants to opioids in
patient-controlled analgesia (PCA) or to local anesthetics
in peripheral and neuraxial nerve blocks was common (8,
9).
Dexmedetomidine is a highly selective and potent cen-
tral alpha-2 adrenergic receptor agonist. Administration
of this adjuvant in miscellaneous methods has received
considerable attention in recent years. Due to its analgesic
and sedative effects, besides the lack of any respiratory-
sparing effects, administration of this adjuvant has been
effective in reducing the need for opioids in the periop-
erative period and may even result in cooperative seda-
tion (10). Given the sympatholytic effects of dexmedetomi-
dine (hypotension and bradycardia), in addition to overse-
dation, especially when administered intravenously or at
high doses, caution must be taken in administering this
drug, especially in elderly patients.
The neuraxial administration of dexmedetomidine
has nociceptive effects on somatic and visceral pains (10).
It also reduces postoperative pain and prolongs analge-
sia, although there is a risk of bradycardia. Various doses
of dexmedetomidine, along with a number of analgesic
drugs, have been used in many studies. However, the ex-
act dose of dexmedetomidine, as an adjuvant drug admin-
istered along with other intravenous drugs in the periop-
erative period, has been controversial.
Regional blocks are one of the most interesting anes-
thetic techniques for many anesthesiologists. They are
among common methods of surgical anesthesia, espe-
cially in surgeries of the upper and lower limbs and ab-
dominal organs in many medical centers (11). They can also
reduce the stress response of general anesthesia, acceler-
ate the ambulation time, decrease the length of hospital-
ization, and consequently, reduce the risk of mortality and
morbidity, especially in high-risk patients (12). One of the
major concerns of medical teams in such cases is the short-
term effects of local anesthetics. Therefore, to prolong the
duration of pain relief, several methods have been pro-
posed, such as continuous peripheral and epidural blocks
and the addition of adjuvant drugs (13).
As mentioned earlier, dexmedetomidine has been used
as an adjuvant to local anesthetics in many peripheral and
neuraxial blocks. In major orthopedic surgeries of the
lower extremities with a painful postoperative period, use
of an adjuvant, such as dexmedetomidine, may have spe-
cial applications, since appropriate pain management in
these patients can lead to their faster return to everyday
life, apart from pain relief (10).
Moreover, administration of adjuvants may be of
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greater interest in geriatric populations, for whom sym-
pathetic blockade may be associated with severe hypoten-
sion and bradycardia due to the administration of local
anesthetics in spinal or epidural anesthesia. On the other
hand, the same side effects can occur following the admin-
istration of dexmedetomidine; therefore, the doses of pre-
scribed drugs (both local anesthetics and adjuvants) must
be carefully adjusted.
In the neuraxial administration of dexmedetomidine
during deliveries, besides surgical anesthesia and pain
management, attention must be paid to the newborns’
complications and the risk of passing the drug through
breastfeeding. Therefore, the beneficial and adverse effects
of analgesic methods and drugs must be carefully weighed
with the physiological conditions of the mother and infant
so as not to enhance the side effects, especially in newborns
(9). The intravenous administration of dexmedetomidine
via PCA, along with other non-opioid analgesic drugs, may
help manage pain and improve patient satisfaction with-
out requiring opioid prescriptions; however, the patient’s
hemodynamics needs to be evaluated due to its sympa-
tholytic effects.
In addition to its use in the management of acute post-
operative pain, dexmedetomidine has also been studied
in chronic pain management procedures. In transforam-
inal epidural steroid injections for the treatment of lum-
bar radiculopathy, the addition of dexmedetomidine as an
adjuvant improves chronic and neuropathic pain and pro-
longs the effects of these procedures (14). Although vari-
ous studies have been published in this area, the exact safe
dose of dexmedetomidine as an adjuvant in perioperative
pain management needs further investigations. The am-
biguity about the safe dose of dexmedetomidine is due to
the fact that the patients’ responses are multifactorial in
nature, and factors, such as the type of the main analgesic,
pain management method, age range, underlying disease,
and type of surgical procedure, can have significant effects
on determining the optimal dose.
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